Pfizer

Why India Should Not Bring A Vaccine Developed By Private Sector Under ‘Compulsory Licence’; History Suggests It Might
Why India Should Not Bring A Vaccine Developed By Private Sector Under ‘Compulsory Licence’; History Suggests It MightSatish ViswanathanSep 15, 2020 07:34 AM
Pfizer And BioNTech Announce Plan To Expand Phase 3 Covid-19 Vaccine Trial By 50% To 44000 Participants
Pfizer And BioNTech Announce Plan To Expand Phase 3 Covid-19 Vaccine Trial By 50% To 44000 ParticipantsSwarajya StaffSep 13, 2020 11:47 AM
With Three Drugmakers In Final Stages Of Testing, US Preparing For Distribution Of Covid-19 Vaccine By 1 November
With Three Drugmakers In Final Stages Of Testing, US Preparing For Distribution Of Covid-19 Vaccine By 1 NovemberSwarajya StaffSep 3, 2020 08:52 AM
President Trump Announces A $1.5 billion Deal with Moderna For 100 Million Doses of Coronavirus Vaccine  
President Trump Announces A $1.5 billion Deal with Moderna For 100 Million Doses of Coronavirus Vaccine  Swarajya StaffAug 12, 2020 06:37 AM
A Tale Of Three Potential Vaccines – How They Stack Up In The Race For Coronavirus Prevention
A Tale Of Three Potential Vaccines – How They Stack Up In The Race For Coronavirus PreventionKaran KambleJul 24, 2020 07:19 AM
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. Government
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. GovernmentSwarajya StaffJul 22, 2020 12:25 PM
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEO
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEOIANSMay 30, 2020 07:36 AM
Kerala Covid-19 Data Storage Row: US Pharma Major Pfizer Obtained Details Of Patients, Allege Reports
Kerala Covid-19 Data Storage Row: US Pharma Major Pfizer Obtained Details Of Patients, Allege ReportsM R SubramaniApr 20, 2020 08:34 AM
Government Offers Interest Waiver If Pharma Companies Agree To Pay Rs 3,500 Crore, Drop All 666 Lawsuits
Government Offers Interest Waiver If Pharma Companies Agree To Pay Rs 3,500 Crore, Drop All 666 LawsuitsSwarajya StaffMay 9, 2019 06:14 AM
Load More